United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024

1. Executive Summary

2. Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024)

3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%)

4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market

• 4.1 Market Drivers
• 4.2 Market Inhibitors

5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024)

• 5.1 Diphtheria, Tetanus & Pertussis (DTap)
  • 5.1.1 Doses Administered (Volume)
  • 5.1.2 Number of Children Being Vaccinated (Volume)
  • 5.1.3 Market Size and Forecast (Value)
• 5.2 Hepatitis A
  • 5.2.1 Doses Administered (Volume)
  • 5.2.2 Number of Children Being Vaccinated (Volume)
  • 5.2.3 Market Size and Forecast (Value)
• 5.3 Varicella / Chicken Pox
  • 5.3.1 Doses Administered (Volume)
  • 5.3.2 Number of Children Being Vaccinated (Volume)
  • 5.3.3 Market Size and Forecast (Value)
• 5.4 Pneumococcal
  • 5.4.1 Doses Administered (Volume)
  • 5.4.2 Number of Children Being Vaccinated (Volume)
  • 5.4.3 Market Size and Forecast (Value)
• 5.5 Haemophilus Influenzae Type B (HIB)
  • 5.5.1 Doses Administered (Volume)
  • 5.5.2 Number of Children Being Vaccinated (Volume)
  • 5.5.3 Market Size and Forecast (Value)
• 5.6 Polio
  • 5.6.1 Doses Administered (Volume)
  • 5.6.2 Number of Children Being Vaccinated (Volume)
  • 5.6.3 Market Size and Forecast (Value)
• 5.7 Rotavirus
  • 5.7.1 Doses Administered (Volume)
  • 5.7.2 Number of Children Being Vaccinated (Volume)
  • 5.7.3 Market Size and Forecast (Value)
• 5.8 Hepatitis B
  • 5.8.1 Doses Administered (Volume)
  • 5.8.2 Number of Children Being Vaccinated (Volume)
  • 5.8.3 Market Size and Forecast (Value)
• 5.9 Influenza Pediatric
  • 5.9.1 Doses Administered (Volume)
  • 5.9.2 Number of Children Being Vaccinated (Volume)
  • 5.9.3 Market Size and Forecast (Value)
• 5.10 Measles, Mumps & Rubella (MMR)
  • 5.10.1 Doses Administered (Volume)
  • 5.10.2 Number of Children Being Vaccinated (Volume)
  • 5.10.3 Market Size and Forecast (Value)

6. Key Companies Analysis

• 6.1 Sanofi Pasteur
  • 6.1.1 Business Overview
  • 6.1.2 Pediatric Vaccine Portfolios
  • 6.1.3 Pedaitric Vaccine – Latest Development & Trends
• 6.2 GlaxoSmithKline (GSK)
  • 6.2.1 Business Overview
  • 6.2.2 Pediatric Vaccine Portfolios
  • 6.2.3 Pediatric Vaccine – Latest Development & Trends
• 6.3 Merck & Co.
  • 6.3.1 Business Overview
  • 6.3.2 Pediatric Vaccine Portfolios
  • 6.3.3 Pediatric Vaccine – Latest Development & Trends
• 6.4 Pfizer Inc.
  • 6.4.1 Business Overview
  • 6.4.2 Pediatric Vaccine Portfolios
  • 6.4.3 Pediatric Vaccine – Latest Development & Trends
• 6.5 Grifols
  • 6.5.1 Business Overview
  • 6.5.2 Pediatric Vaccine Portfolios
  • 6.5.3 Pediatric Vaccine – Latest Development & Trends

List of Tables:

Table 3–1: United States Pediatric Vaccines Market Share (Percent), 2010 – 2016

Table 3–2: United States Pediatric Vaccine Market Share Forecast (Percent), 2017 – 2024

List of Figures:

Figure 2–1: United States Pediatric Vaccine Market (Million US$), 2010 – 2016

Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2017 – 2024

Figure 4–19: DTap Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–20: DTap Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–21: Number of Children Being Vaccinated with DTap Vaccine (in Million),2010 – 2016

Figure 4–22: Number of Children Being Vaccinated with DTap Vaccine Forecast (in Million),2017 – 2024

Figure 4–23: DTap Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–24: DTap Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–43: Hepatitis A Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–44: Hepatitis A Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–45: Number of Children Being Vaccinated with Hepatitis A Vaccine (in Million),2010 – 2016

Figure 4–46: Number of Children Being Vaccinated with Hepatitis A Vaccine Forecast (in Million),2017 – 2024

Figure 4–47: Hepatitis A Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–48: Hepatitis A Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–49: Varicella Vaccine Doses Administered (in Million), 2010–2016

Figure 4–50: Varicella Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–51: Number of Children Being Vaccinated with Varicella Vaccine (in Million),2010 – 2016

Figure 4–52: Number of Children Being Vaccinated with Varicella Vaccine Forecast (in Million),2017 – 2024

Figure 4–53: Varicella Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–54: Varicella Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–25: Pneumococcal Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–26: Pneumococcal Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–27: Number of Children Being Vaccinated with Pneumococcal Vaccine (in Million),2010 – 2016

Figure 4–28: Number of Children Being Vaccinated with Pneumococcal Vaccine Forecast (in Million),2017 – 2024

Figure 4–29: Pneumococcal Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–30: Pneumococcal Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–7: HIB Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–8: HIB Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–9: Number of Children Being Vaccinated with HIB Vaccine (in Million),2010 – 2016

Figure 4–10: Number of Children Being Vaccinated with HIB Vaccine Forecast (in Million),2017 – 2024

Figure 4–11: HIB Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–12: HIB Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–13: Polio Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–14: Polio Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–15: Number of Children Being Vaccinated with Polio Vaccine (in Million),2010 – 2016

Figure 4–16: Number of Children Being Vaccinated with Polio Vaccine Forecast (in Million),2017 – 2024

Figure 4–17: Polio Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–18: Polio Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–31: Rotavirus Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–32: Rotavirus Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–33: Number of Children Being Vaccinated with Rotavirus Vaccine (in Million),2010 – 2016

Figure 4–34: Number of Children Being Vaccinated with Rotavirus Vaccine Forecast (in Million),2017 – 2024

Figure 4–35: Rotavirus Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–36: Rotavirus Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–37: Hepatitis B Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–38: Hepatitis B Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–39: Number of Children Being Vaccinated with Hepatitis B Vaccine (in Million),2010 – 2016

Figure 4–40: Number of Children Being Vaccinated with Hepatitis B Vaccine Forecast (in Million),2017 – 2024

Figure 4–41: Hepatitis B Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–42: Hepatitis B Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–55: Influenza Pediatric Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–56: Influenza Pediatric Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–57: Number of Children Being Vaccinated with Influenza Pediatric Vaccine (in Million),2010 – 2016

Figure 4–58: Number of Children Being Vaccinated with Influenza Pediatric Vaccine Forecast (in Million),2017 – 2024

Figure 4–59: Influenza Pediatric Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–60: Influenza Pediatric Vaccine Market Value Forecast (in Million US$), 2017 – 2024

Figure 4–1: MMR Vaccine Doses Administered (in Million), 2010 – 2016

Figure 4–2: MMR Vaccine Doses Administered Forecast (in Million), 2017 – 2024

Figure 4–3: Number of Children Being Vaccinated with MMR Vaccine (in Million),2010 – 2016

Figure 4–4: Number of Children Being Vaccinated with MMR Vaccine Forecast (in Million),2017 – 2024

Figure 4–5: MMR Vaccine Market Value (in Million US$), 2010 – 2016

Figure 4–6: MMR Vaccine Market Value Forecast (in Million US$), 2017 – 2024